PRKN and cardiomyopathy: The inhibition of PINK1/Parkin-mediated mitophagy in HFD-induced cardiomyopathy is primarily regulated by BRD4 and ACC2, suggesting potential therapeutic targets to modulate mitophagy and mitigate disease progression.